Results 141 to 150 of about 12,924 (209)

An Italian cartography of VEXAS‐related thrombosis

open access: yesHemaSphere, Volume 10, Issue 8, August 2026.
Abstract Thrombotic events (TEs) occur in up to 40% of patients with vacuoles, E1 enzyme, X‐linked, autoinflammatory, and somatic (VEXAS) syndrome, but data on its clinical‐genomics features and anticoagulation strategies are limited. To gain more insight into this, we conducted a two‐step study evaluating the prevalence and outcome of TE in VEXAS ...
Giorgia Ranucci   +42 more
wiley   +1 more source

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 8, August 2026.
Abstract Ischemic stroke remains a leading cause of death and disability worldwide, and bleeding (particularly intracranial hemorrhage) continues to limit conventional antithrombotic therapy in secondary prevention, even with direct oral anticoagulants.
Federica Ferrari, Roberto Federico Villa
wiley   +1 more source

The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes

open access: yeseJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Objectives: To study the predictive and prognostic values of serum erythropoietin levels (sEPO) measured at diagnosis in lower‐risk myelodysplastic syndromes. Methods: We analyzed clinical associations and prognosis with sEPO in 672/1610 patients with at least one year of follow‐up data in the prospective EUMDS study.
Dominic Culligan   +19 more
wiley   +1 more source

Integrated Hospital, Emergency Department, and Community Surveillance for Respiratory Viruses in Milan, Italy

open access: yesJournal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT Respiratory virus circulation may vary across healthcare settings and age groups, potentially limiting the interpretability of surveillance based on a single source. In Milan, Italy, established community‐ and emergency department‐based systems coexist with hospital laboratory testing, but hospital ward‐level data are not routinely integrated.
Alberto Rizzo   +22 more
wiley   +1 more source

Universal‐Bac3Gel: A 3D Biofilm‐Relevant Matrix That Supports In Vitro Growth and Biofilm Formation of ESKAPE Pathogens

open access: yesMicrobiologyOpen, Volume 15, Issue 4, August 2026.
Universal‐Bac3Gel, a 3D biofilm‐relevant matrix with oxygen and nutrient gradients, supports the growth and species‐specific biofilm architectures of all ESKAPE pathogens, offering a physiologically relevant platform for antimicrobial testing and microbiological research. ABSTRACT Human microbiota is increasingly considered to shape health and disease,
Emanuela Peluso   +5 more
wiley   +1 more source

The Pain in Dystonia Scale (PIDS)—Validation in Craniofacial and Upper Limb Dystonia

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 8, Page 1933-1939, August 2026.
ABSTRACT Background Pain is one of the most disabling non‐motor symptoms in adult‐onset isolated dystonia (AOID). The Pain in Dystonia Scale (PIDS) was developed and validated in cervical dystonia. Its applicability to other focal subtypes remains unknown.
Veronica Bruno   +24 more
wiley   +1 more source

Novel Clinical and Neurophysiological Insights in Neonatal‐Onset 3‐Methylglutaconic Aciduria Type VIII due to HTRA2 Mutations

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 8, August 2026.
This report expands the limited available data on type VIII 3‐methylglutaconic aciduria (MGCA8), a neurodegenerative disorder which involves biallelic pathogenic variants of HTRA2 gene. The mutation of this gene leads to mitochondrial dysfunction and altered apoptosis regulation, especially in the brain.
Barbara Belmessieri   +7 more
wiley   +1 more source

Modelling dose and dose‐averaged linear energy transfer to predict high‐grade temporal lobe necrosis following skull‐base proton therapy

open access: yesMedical Physics, Volume 53, Issue 8, August 2026.
Abstract Background In skull‐base proton therapy (PT), severe toxicity outcomes such as temporal lobe necrosis (TLN) may be associated with inadequate management of the actual radiobiological effectiveness (RBE) of proton beams. Combining dose‐averaged linear energy transfer (LETd) and dose may be crucial in treatment plan optimization and evaluation ...
Giulia Fontana   +9 more
wiley   +1 more source

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long‐term results from FIL‐FLAZ12 Phase III trial

open access: yes
HemaSphere, Volume 10, Issue 8, August 2026.
Rita Tavarozzi   +46 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

The Pavia consensus statement

AIDS, 2003
abstract not ...
Volberding, Pa   +18 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy